SCHEMBL10074249

SCHEMBL10074249

OCc1cccc(/C=N/Nc2cc(N3CCCCC3)nc(OCCc3ccccn3)n2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 2/20 0.67
SYK P43405 2/20 0.67
IRAK4 Q9NWZ3 2/20 0.67
FES P07332 1/20 0.67
FER P16591 1/20 0.67
FRK P42685 1/20 0.67
CAMK1D Q8IU85 1/20 0.67
PIKFYVE Q9Y2I7 1/20 0.67
SENP6 Q9GZR1 8/20 0.51
MAPT P10636 8/20 0.51
SENP7 Q9BQF6 7/20 0.51
LMNA P02545 6/20 0.51
APAF1 O14727 5/20 0.51
SENP8 Q96LD8 4/20 0.51
PPP1CA P62136 2/20 0.51
BRSK1 Q8TDC3 1/20 0.51
KDM4E B2RXH2 8/20 0.43
GAA P10253 4/20 0.43
POLB P06746 2/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL425075 0.92 TYK2 (0.79) TYK2SYKIRAK4FESFER
SCHEMBL425074 0.92 TYK2 (0.79) TYK2SYKIRAK4FESFER
SCHEMBL13759326 0.92 TYK2 (0.69) TYK2SYKIRAK4FESFER
SCHEMBL424838 0.88 TYK2 (0.84) TYK2SYKIRAK4FESFER
SCHEMBL13759120 0.88 TYK2 (0.69) TYK2SYKIRAK4FESFER
SCHEMBL13758964 0.88 TYK2 (0.69) TYK2SYKIRAK4FESFER
SCHEMBL13758968 0.88 TYK2 (0.69) TYK2SYKIRAK4FESFER
SCHEMBL13758961 0.88 TYK2 (0.69) TYK2SYKIRAK4FESFER
SCHEMBL424837 0.88 TYK2 (0.84) TYK2SYKIRAK4FESFER
SCHEMBL428108 0.87 TYK2 (0.86) TYK2SYKIRAK4FESFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458687-B1 PYRIMIDINE COMPOUNDS AS INTERLEUKIN-12 (IL-12) INHIBITORS SYNTA PHARMACEUTICALS CORP (US) 2012-01-11 EP disclosed
WO-2009100406-A2 TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS SYNTA PHARMACEUTICALS CORP. (US) 2009-08-13 WO disclosed
WO-2007050980-A2 PROCESS FOR PREPARING MESYLATE SALTS OF IL-12 INHIBITORY COMPOUNDS SYNTA PHARMACEUTICALS CORP. (US) 2007-05-03 WO disclosed